Search for: "In Interest of Ep" Results 21 - 40 of 1,004
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Feb 2024, 5:17 am by Kluwer Patent blogger
In a press release issued two weeks ago, when the Committee on Environment, Public Health and Food of the EP had adopted the proposal, the lobby group IFOAM Organics Europe wrote: ‘This rushed legislative process to deregulate NGTs goes against the interest of European breeders, farmers and citizens. [read post]
4 Feb 2024, 7:14 am by Simon Holzer (MLL Legal Ltd.)
The basic patent EP 1 412 357 B1 relates to the treatment of diseases in which the activity of DP IV enzymes is involved, such as diabetes, characterized by elevated plasma glucose levels or hyperglycemia in the fasting state or after administration of glucose during an oral glucose tolerance test. [read post]
25 Jan 2024, 2:59 am by Kirston
THE ROLE: You will work on an interesting case load of all aspects of family law You will play an active role in Business Development. [read post]
22 Jan 2024, 1:30 am by Marta Morvillo
The result was a watered-down proposal, which was ultimately voted down by the EP. [read post]
7 Jan 2024, 9:34 am by Rose Hughes
 Use of the application as filed and prosecution history in the claim interpretationIt is at this juncture that things start getting interesting. [read post]
3 Jan 2024, 1:36 pm by The White Law Group
(NYSE:AHT) surpassed analyst EPS estimates but reported a loss due to high interest expenses. [read post]
1 Jan 2024, 12:32 pm
  One of the more interesting manifestations of the role of religion within political life is that of the priests of the practitioners of the old religions of Africa as re-established in the Western Hemisphere, particularly in Marxist-Leninist Cuba. [read post]
10 Dec 2023, 10:30 pm by Vasiliki Kosta
Namely, that it should serve politico-economic interests (Mager) and follow the rationality of those other systems of society rather than its own rationality (Grimm). [read post]
17 Nov 2023, 6:00 am by Gregory Bacon (Bristows)
Multiple parallel cases This was an interesting feature of the Ocado v AutoStore litigation. [read post]
14 Nov 2023, 5:29 am by Greg Lambert and Marlene Gebauer
Vanderbilt Law School recently launched an exciting new initiative called the Vanderbilt AI Legal Lab (VAILL) to explore how artificial intelligence can transform legal services and access to justice. [read post]
14 Nov 2023, 4:18 am by Chloe Dickson (Bristows)
  The Claimants (“PMI”) sought revocation of EP (UK) No. 3 367 830 B1 (“EP 830”) and the defendants (“BAT”) counterclaimed for infringement. [read post]
9 Nov 2023, 9:05 pm by renholding
Since we are interested in understanding how non-earnings vesting conditions affect executive earnings management and reporting incentives, we focus on equity grants that vest based on the level or growth of one earnings metric (i.e., EPS, operating income, net income, EBITDA, EBT, EBIT) as either single-vesting metrics (the baseline in our models) or in conjunction with stock returns or other non-earnings metrics. [read post]
6 Nov 2023, 12:25 pm by Populus Radio, Robert Ambrogi
Michel also alleges that Kenner and cocounsel Alon Israely had undisclosed financial interests in the AI company that motivated them to use the AI in his case as a marketing ploy. [read post]
6 Nov 2023, 5:51 am by Rose Hughes
  Case backgroundAstellas alleged that sale of Teva's and Sandoz's generic mirabegron products would infringe Astella's formulation patent EP (UK) 2345410. [read post]
1 Nov 2023, 3:19 am by Lucie Fortune (Bristows)
The EP was granted in 2021 for the 17 UPC countries plus Spain and the UK, and was not opted out of the UPC. [read post]
30 Oct 2023, 3:26 pm by Greg Lambert
On a special “on location” episode of The Geek in Review, Greg Lambert sits down with ⁠vLex⁠’s ⁠Damien Riehl⁠ for a hands-on demonstration of the new generative AI tool called Vincent AI. [read post]
25 Oct 2023, 9:01 pm by renholding
If, as the Barr Report alleges, the Federal Reserve’s implementation of the tailoring requirement in the Economic Growth, Regulatory Relief, and Consumer Protection Act (EGRRCPA)3 was a major factor in the staff’s failure to detect or take prompt action to remediate SVB’s deficiencies in managing its liquidity and interest rate risks, then it would be appropriate to question whether that regulatory tailoring should be modified or eliminated consistent with the… [read post]
17 Oct 2023, 3:40 pm by Rik Lambers (Brinkhof)
Grünenthal markets Nebido and holds a related patent (EP 1 457 208 – expiration March 2024). [read post]